TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Integral Diagnostics Ltd. ( (AU:IDX) ) has provided an announcement.
Integral Diagnostics Ltd. has announced its 2025 Annual General Meeting scheduled for 31 October 2025, allowing shareholders to participate either in person or online. This meeting is a significant event for the company as it provides an opportunity for stakeholders to engage with the company’s leadership and discuss future strategies, potentially impacting its operations and market positioning.
The most recent analyst rating on (AU:IDX) stock is a Hold with a A$3.00 price target. To see the full list of analyst forecasts on Integral Diagnostics Ltd. stock, see the AU:IDX Stock Forecast page.
More about Integral Diagnostics Ltd.
Integral Diagnostics (IDX) is a leading provider of medical imaging services across Australia and New Zealand, employing some of Australasia’s leading radiologists and diagnostic imaging specialists. The company operates under a unique medical leadership model to ensure quality patient care, service, and access.
Average Trading Volume: 1,091,502
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$1.05B
Learn more about IDX stock on TipRanks’ Stock Analysis page.